Company Filing History:
1 out of 1 
1 out of 832,880 Years Active: 2003-2013
Title: Katarina Edwards: Innovator in Cancer Therapy
Introduction
Katarina Edwards is a prominent inventor based in Uppsala, Sweden. She has made significant contributions to the field of cancer therapy through her innovative inventions. With a total of two patents to her name, her work focuses on improving cancer treatment and diagnosis.
Latest Patents
Katarina's latest patents include anthracycline derivatives that are suitable for use in cancer therapy and diagnosis. These anthracycline derivatives can be radiolabelled and utilized as imaging agents in cancer diagnosis. Additionally, they can be combined with a drug delivery system that employs a two-step targeting strategy for treating both solid and disseminated tumors. This drug delivery system is particularly advantageous for the treatment and diagnosis of breast cancer. Another significant invention is a drug delivery system with two-step targeting, which consists of a lipid carrier equipped with cell targeting agents to direct the system to specific cells or tissues. This system also encloses a drug with a DNA targeting agent aimed at delivering the drug to the nuclei of targeted cells. The method of cancer therapy using this system aims to treat or analyze both large tumor masses and small tumor cell clusters, enhancing drug uptake in tumors while minimizing interaction with healthy organs.
Career Highlights
Throughout her career, Katarina has worked with various companies, including Nuclisome AB. Her innovative approaches have positioned her as a key figure in the development of advanced cancer therapies.
Collaborations
Katarina has collaborated with notable individuals in her field, including Jörgen Carlsson and Stefan Sjöberg. Their combined expertise has contributed to the advancement of her research and inventions.
Conclusion
Katarina Edwards is a trailblazer in the realm of cancer therapy, with her inventions paving the way for more effective treatment options. Her work exemplifies the potential of innovation in improving patient outcomes in the fight against cancer.